Lupin today announced that it has received approval from the United States Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA Diclofenac Sodium Topical Solution USP 2Percentage ww to market a generic equivalent of Pennsaid Topical Solution 2Percentage ww of Horizon Pharma Ireland DAC The product will be manufactured at Lupins facility in Pithampur India Diclofenac Sodium Topical Solution USP 2Percentage ww RLD Pennsaid had estimated annual sales of USD 484 million in the US IQVIA MAT June 2022
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
